Business Description
Imugene Ltd
ISIN : AU000000IMU9
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 252.07 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -38.7 | |||||
3-Year EPS without NRI Growth Rate | -26 | |||||
3-Year FCF Growth Rate | -18.6 | |||||
3-Year Book Growth Rate | 28.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.92 | |||||
9-Day RSI | 33.4 | |||||
14-Day RSI | 34.57 | |||||
6-1 Month Momentum % | 59.09 | |||||
12-1 Month Momentum % | -12.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.73 | |||||
Quick Ratio | 5.73 | |||||
Cash Ratio | 4.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.2 | |||||
Shareholder Yield % | -8.7 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -45.23 | |||||
ROA % | -41.83 | |||||
ROIC % | -183.06 | |||||
ROC (Joel Greenblatt) % | -745.25 | |||||
ROCE % | -48.45 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.85 | |||||
Price-to-Tangible-Book | 3.8 | |||||
EV-to-EBIT | -4.04 | |||||
EV-to-Forward-EBIT | -10.28 | |||||
EV-to-EBITDA | -4.04 | |||||
EV-to-Forward-EBITDA | -8.39 | |||||
EV-to-FCF | -5.45 | |||||
Price-to-Net-Current-Asset-Value | 3.8 | |||||
Price-to-Net-Cash | 7.6 | |||||
Earnings Yield (Greenblatt) % | -24.76 | |||||
FCF Yield % | -14.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Imugene Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | |||
EPS (TTM) (A$) | -0.013 | ||
Beta | 3.35 | ||
Volatility % | 173.78 | ||
14-Day RSI | 34.57 | ||
14-Day ATR (A$) | 0.00614 | ||
20-Day SMA (A$) | 0.08515 | ||
12-1 Month Momentum % | -12.5 | ||
52-Week Range (A$) | 0.039 - 0.15 | ||
Shares Outstanding (Mil) | 7,481.1 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Imugene Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Imugene Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Imugene Ltd Frequently Asked Questions
What is Imugene Ltd(ASX:IMU)'s stock price today?
When is next earnings date of Imugene Ltd(ASX:IMU)?
Does Imugene Ltd(ASX:IMU) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |